Acadia Pharmaceuticals Inc.
corporate_fare Company Profile
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for ACAD at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Acadia Pharmaceuticals Reports Strong Q4 & Full Year 2025 Results, Exceeds $1B Revenue, and Issues Positive 2026 Guidance
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.07B
Net Income
$391M
Diluted EPS
$2.30
Op. Cash Flow
$109.84M
Free Cash Flow
$105.15M
Gross Profit
$982.51M
Operating Income
$104.81M
Cash & Equivalents
$177.69M
Debt / Equity
0.00×
Net Margin
36.5%
Shares Outstanding
170.31M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-072519
show_chartPrice Chart
Loading chart...
feed ACAD - Filings & News (Page 2)
ACAD
Feb 25, 2026, 4:20 PM EST
Price at Filing:
$26.00
Real-time Price:
$17.12
Change:
-$8.88 (-34%)
Market Cap:
$2.957B